Asterias Biotherapeutics, Inc., a Subsidiary of BioTime, Inc., Acquires Geron’s Embryonic Stem Cell Assets

Asterias Biotherapeutics, Inc. and BioTime, Inc. jointly announced today the closing of the transactions under the Asset Contribution Agreement wi

[Read the full article here]

Comments are closed.